Pegilodecakin Active Not Recruiting Phase 1 Trials for Solid Tumors / Colorectal Carcinoma (CRC) / Pancreatic Carcinoma / Melanoma / Ovarian Cancer / Renal Cell Carcinoma (RCC) / Breast Cancer / Prostate Cancer / Non-Small Cell Lung Carcinoma Treatment

Indications	Status	Purpose	Phase
DBCOND0029860 (Solid Tumors) DBCOND0105237 (Colorectal Carcinoma (CRC)) DBCOND0036460 (Pancreatic Carcinoma) DBCOND0020306 (Melanoma) DBCOND0028213 (Ovarian Cancer) DBCOND0038284 (Renal Cell Carcinoma (RCC)) DBCOND0028036 (Breast Cancer) DBCOND0062462 (Prostate Cancer) DBCOND0030527 (Non-Small Cell Lung Carcinoma)	Active Not Recruiting	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT02009449	A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors	Capecitabine (DB01101) Carboplatin (DB00958) Cisplatin (DB00515) Docetaxel (DB01248) Fluorouracil (DB00544) Gemcitabine (DB00441) Interleukin-10 (DB12880) Leucovorin (DB00650) Nivolumab (DB09035) Oxaliplatin (DB00526) Paclitaxel (DB01229) Pazopanib (DB06589) Pegilodecakin (DB15162) Pembrolizumab (DB09037)